Skip to main content
Equibles

EverSource Wealth Advisors, LLC

Position in CLLS — Cellectis S.A.

CIK 1710537 BIRMINGHAM, AL
Back to CLLS Full portfolio

Position in CLLS

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$39
-$2 QoQ
Shares Held
13
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 27 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

EverSource Wealth Advisors, LLC holds $15,249,118 across 258 Biotechnology names. CLLS ranks #255 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CRSP
CRISPR Therapeutics AG
 110,689 $6,036,977
2 INCY
Incyte Corp
 9,004 $1,020,689
3 RPRX
Royalty Pharma plc
 13,228 $741,689
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,357 $674,058
5 REGN
Regeneron Pharmaceuticals, Inc.
 912 $568,663
6 BEAM
Beam Therapeutics Inc.
 16,556 $568,200
7 EXEL
Exelixis, Inc.
 8,321 $452,739
8 HALO
Halozyme Therapeutics, Inc.
 4,146 $324,502

All Filings in CLLS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $39 13
2026-03-31 $41 13
2025-12-31 $947 196
2025-09-30 $558 196
2025-06-30 $19 13
2025-03-31 $16 13
2024-12-31 $23 13
2024-09-30 $27 13
2024-06-30 $24 13
2024-03-31 $34 13
2023-12-31 $40 13
2023-09-30 $20 13
2023-06-30 $25 13
2023-03-31 $25 13